Bioventus BVS

$ 11.36 -0.44%

Quarterly report 2024-Q3
added 11-05-2024

Bioventus Financial Statements 2011-2024 | BVS

Annual Financial Statements Bioventus

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	351 M	82.3 M	593 M	-	-	-	-	-	-	-	-	-	-
Shares	62.6 M	61.4 M	45.5 M	-	-	-	-	-	-	-	-	-	-
Historical Prices	5.6	1.34	13	-	-	-	-	-	-	-	-	-	-
Net Income	-156 M	-159 M	19.4 M	16.4 M	6.85 M	-12.2 M	-	-	-	-	-	-	-
Revenue	512 M	512 M	431 M	321 M	340 M	319 M	-	-	-	-	-	-	-
Cost of Revenue	184 M	181 M	128 M	87.6 M	90.9 M	-	-	-	-	-	-	-	-
Gross Profit	328 M	331 M	303 M	234 M	249 M	235 M	-	-	-	-	-	-	-
Operating Income	-81.7 M	-167 M	12.1 M	21.2 M	31.2 M	-	-	-	-	-	-	-	-
Interest Expense	1.29 M	-9.77 M	-1.46 M	4.43 M	75 K	-	-	-	-	-	-	-	-
EBITDA	-24.4 M	-112 M	46.9 M	49.9 M	39.7 M	36 M	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	217 M	208 M	-	-	-	-	-	-	-
General and Administrative Expenses	304 M	332 M	254 M	193 M	198 M	192 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Bioventus

	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	65.3 M	64.1 M	63.4 M	62.8 M	62.6 M	62.1 M	-	61.7 M	61.5 M	60.5 M	-	41.8 M	41.8 M	41.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-4.82 M	-24 M	-4.57 M	-7.3 M	-3.68 M	-139 M	-	-108 M	-7.25 M	-11.3 M	-	-1.07 M	-4.13 M	26 M	-	8.46 M	-5.77 M	10.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	139 M	151 M	129 M	121 M	137 M	119 M	-	129 M	140 M	117 M	-	109 M	110 M	81.8 M	-	85.9 M	58 M	78.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	45.4 M	47.6 M	41.1 M	41.9 M	47.9 M	45.1 M	-	44.1 M	43.7 M	41.6 M	-	29.8 M	33.5 M	22.2 M	-	23.4 M	17.7 M	21.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	93.6 M	104 M	88.4 M	78.8 M	89.1 M	73.9 M	-	84.5 M	96.7 M	75.7 M	-	79.1 M	76.3 M	59.6 M	-	62.5 M	40.3 M	57.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	4.07 M	-29.4 M	5.33 M	2.42 M	6.75 M	-92.1 M	-	-127 M	-3.31 M	-21.4 M	-	-1.05 M	-5.74 M	22 M	-	6.93 M	-4.59 M	13 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	626 K	-159 K	-63 K	-494 K	-513 K	1.59 M	-	-115 K	-604 K	363 K	-	-757 K	-1.64 M	-419 K	-	3.28 M	1.34 M	-2.46 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	6.14 M	-27.3 M	17.1 M	4.74 M	9.04 M	-75.6 M	-	-125 M	-612 K	-8.97 M	-	22.1 M	8.92 M	29.2 M	-	28.7 M	9.92 M	20.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	81.1 M	94.8 M	78.4 M	69.8 M	74.8 M	80.9 M	-	79 M	89.6 M	86.1 M	-	69.6 M	69 M	34.7 M	-	50.3 M	40.5 M	40.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency